Journal
PSYCHIATRY RESEARCH
Volume 206, Issue 1, Pages 22-25Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.psychres.2012.09.051
Keywords
Ghrelin; Obestatin; SNP; Anxiety; rs4684677; Gln90Leu; Panic disorder
Categories
Funding
- Swedish Research Council for Medicine [2009-S266]
- European Commission [FP7-HEALTH-2009-241592, FP7-KBBE-2009-3-245009, FP7-KBBE-2010-4-266408]
- FOU/ALF Goteborg [ALFGBG-138741]
- Swedish Foundation for Strategic Research [A305-188]
- Novo Nordisk Fonden [NNF12OC1016479] Funding Source: researchfish
Ask authors/readers for more resources
The aim of the study was to investigate whether polymorphisms in the preproghrelin gene are associated with anxiety disorders, such as panic disorder, in humans. Panic disorder is a severe anxiety disorder, characterized by sudden attacks of intense fear or anxiety in combination with somatic symptoms. The preproghrelin gene codes for two gut-derived circulating peptides that have been linked to anxiety-like behaviour in rodents: ghrelin (an orexigenic, pro-obesity hormone) and obestatin. In the present study, we genotyped three missense mutations in the preproghrelin gene in 215 patients suffering from panic disorder and in 451 controls. The A allele of the rs4684677 polymorphism was significantly associated with panic disorder, while there were no significant associations with the two other polymorphisms studied. We conclude that the rs4684677 (Gln90Leu) polymorphism in the preproghrelin gene may be associated with increased risk of panic disorder. It will be important to confirm these findings in additional panic disorder patient groups. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available